Paclitaxel-Coated Balloon Angioplasty vs. Plain Balloon Dilation for the Treatment of Failing Dialysis Access:6-Month Interim Results From a Prospective Randomized Controlled Trial
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
PURPOSE: To report the 6-month results of a prospective randomized trial investigating angioplasty with paclitaxel-coated balloons (PCB) vs. plain balloon angioplasty (BA) for the treatment of failing native arteriovenous fistulae (AVF) or prosthetic arteriovenous grafts (AVG). METHODS: The enrollment criteria for this non-inferiority hypothesis trial included clinical signs of failing dialysis access with angiographic documentation of a significant venous stenotic lesion in patients with AVF or AVG circuits. From March to December 2010, 40 patients (29 men; mean age 64.1 ± 14.3 years) were randomized to undergo either PCB dilation (n = 20) or standard BA (n = 20) of a stenosed venous outflow lesion. Regular angiographic follow-up was scheduled bimonthly. Study outcome measures included device success (<30% residual stenosis without postdilation), procedural success (<30% residual stenosis), and primary patency of the treated lesion (<50% angiographic restenosis and no need for any interim repeat procedures). RESULTS: Baseline and procedural variables were comparably distributed between both groups. Device success was 9/20 (45%) for the PCB device vs. 20/20 (100%) for standard control BA (p<0.001). Procedural success was 100% in both groups after further high-pressure post-dilation as necessary. There were no major or minor complications in either group. At 6 months, cumulative target lesion primary patency was significantly higher after PCB application (70% in PCB group vs. 25% in BA group, p<0.001; HR 0.30, 95% CI 0.12 to 0.71, p<0.006). CONCLUSION: PCB angioplasty improves patency after angioplasty of venous stenoses of failing vascular access used for dialysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179 · cited 1×
“In uremic patients, the endothelial dysfunction may exaggerate any preexisting venous neointimal hyperplasia, medial hypertrophy, and vessel wall intima-media thickening that may be present even before vascular access formation.(20,21,23)”
BackgroundTreatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter
Scheller, B., Hehrlein, C., Bocksch, W., Rutsch, W., Haghi, D., Dietz, U., Böhm, M., & Speck, U. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061254 · Cited by 816
III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000
(2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)70007-8 · Cited by 806
Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg
Tepe, G., Zeller, T., Albrecht, T., Heller, S., Schwarzwälder, U., Beregi, J.-P., Claussen, M. D. C. D., Oldenburg, A., Scheller, B., & Speck, U. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706356 · Cited by 803 · cited 1×
“One such approach could be the use of angioplasty with paclitaxel-coated balloons (PCBs), which are already known to effectively inhibit neointimal hyperplasia and reduce vascular restenosis after angioplasty of the superficial femoral artery for leg ischemia.(18) We sought to compare the performance of PCBs vs.”
BackgroundHemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint
Roy-Chaudhury, P., Sukhatme, V. P., & Cheung, A. K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050615 · Cited by 584 · cited 2×
“The initial events of neointimal hyperplasia include trauma at the time of vascular access creation, elevated hemodynamic shear stress across the dialysis circuit, vessel injury from dialysis needle punctures, uremia resulting in endothelial dysfunction, and repeated angioplasties that may exacerbate endothelial injur…”
BackgroundUnverdorben, M., Vallbracht, C., Cremers, B., Heuer, H., Hengstenberg, C., Maikowski, C., Werner, G. S., Antoni, D., Kleber, F. X., Bocksch, W., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839282 · Cited by 511
Stent Graft versus Balloon Angioplasty for Failing Dialysis-Access Grafts
Haskal, Z. J., Trerotola, S., Dolmatch, B., Schuman, E., Altman, S., Mietling, S., Berman, S., McLennan, G., Trimmer, C., Ross, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902045 · Cited by 422
Huber, T. S., Carter, J. W., Carter, R. L., & Seeger, J. M. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00426-9 · Cited by 418 · cited 1×
“However, these conduits are characterized by a high rate of late failure, mainly because of stenosis developing in the venous component.(3,4) Dysfunction of the dialysis circuit is a significant cause of morbidity and mortality in patients undergoing hemodialysis and can eventually lead to loss of vascular access.”
BackgroundUnited States Renal Data System 2007 Annual Data Report Abstract
Collins, A. J., Foley, R., Herzog, C., Chavers, B., Gilbertson, D., Ishani, A., Kasiske, B., Liu, J., Mau, L.-W., McBean, M., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.001 · Cited by 344
Lee, T., & Roy-Chaudhury, P. (2009) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2009.06.009 · Cited by 287 · cited 3×
“The vessel injury leads to downstream events (oxidative stress, inflammation, endothelial dysfunction, alternative origins for neointimal cells) that trigger the migration of vascular SMCs from the media to the intima, precipitating neointimal hyperplasia.(12,13,24) The same causes generally account for venous AVF ste…”
Background
Cited by
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Guía Clínica Española del Acceso Vascular para Hemodiálisis
Ibeas, J., Roca-Tey, R., Vallespín, J., Moreno, T., Moñux, G., Martí-Monrós, A., del Pozo, J. L., Gruss, E., Ramírez de Arellano, M., Fontseré, N., et al. (2017) · Nefrología · doi:10.1016/j.nefro.2017.11.004 · Cited by 214
Metadata
- Authors
- Katsanos, K., Karnabatidis, D., Kitrou, P., Spiliopoulos, S., Christeas, N., & Siablis, D.
- Venue
- Journal of Endovascular Therapy
- Published
- 2012-04
- Volume
- 19
- Issue
- 2
- Pages
- 263-272
- ISSN
- 1526-6028 (ISSN-L)
- 1545-1550
- OpenAlex
- W1976458283
- Cited by
- 160
- References
- 22
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.